In a remarkable stride towards its vision of driving measurable success through best business practices, Endeavour Group has announced a funding milestone of $383 million. This significant capital infusion underscores the market’s confidence in Endeavour Group's innovative approach to business services. Renowned for offering a comprehensive suite of resources, Endeavour specializes in sales and marketing consulting tailored mainly for the food and drink industry, customer service training, and small business management consulting. With this latest round of funding, the company aims to enhance its training services and expand its resources, empowering businesses to not only survive but thrive in the current challenging economic landscape. The infusion of capital will primarily be directed towards developing cutting-edge tools and programs that equip companies with the skills necessary to gain a competitive edge. More importantly, as the world moves towards stronger economic recovery, Endeavour’s services will be pivotal in preparing businesses for an inevitable rebound, allowing them to scale, innovate, and connect better with their customers. This funding marks a transformative moment for Endeavour Group, enabling the team to further its mission of elevating business success based on sound educational principles and cutting-edge market strategies. With the commitment to empowering businesses through education and actionable insights, Endeavour is positioned not just as a consultant, but as a strategic partner in redefining industry standards in a post-pandemic world. Stay tuned as Endeavour Group continues to pave the way for informed business practices and measurable results.
Endeavour Group Secures $383M Funding to Drive Business Growth and Success
Get the full Endeavour Group company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
White Circle
White Circle is the control layer for AI in production. We help companies test, protect, observe, and improve every AI interaction — from blocking unsafe inputs and preventing jailbreaks to analyzing user behavior and optimizing model performance.
$11.0M Seed
today
Hoplon AI
Human Convesation, Super Human Protection - Always on
$1.0M Seed
today
Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
$2.1B Series b
today
Sensible Medical Innovations Ltd.
Sensible Medical has developed a non-invasive fluid status monitor (ReDS) for accurate measurement and monitoring of lung fluid for heart failure patients.
$20.0M Unknown
today
Replenish, Inc.
Replenish, Inc. developed the world's smallest implantable, refillable drug pump for the $7 billion retinal therapeutic market (pump currently in clinical investigation, not yet approved by FDA for sale). The MicroPump is implanted under the eye's skin for the purpose of periodically injecting sight-saving medication for patients with age related macular degeneration (AMD). After a 20 minute outpatient surgical procedure, the pump is programmed and recharged wirelessly by the physician and refilled ever 6 months to deliver biotech protein therapies that could only be otherwise administered by a physician's syringe every 4 weeks for life. See our website at www.replenishinc.com for more information.
$100.0K Unknown
today